How to Navigate Ecosystem Connect NEWDistinguished Investigators Global Conferences RLT Education RLT Components Sponsors Trial Stats
Evaluation of Somatostatin Receptor Expression in PET 68Ga-DOTATOC in Patients Followed for Metastatic Breast Cancer
Description:
DOTABREAST: Evaluation of Somatostatin Receptor Expression in PET 68Ga-DOTATOC in Patients Followed for Metastatic Breast Cancer This is a prospective, monocentric, non-controlled, non-randomized, open-label, interventional study.
Sponsor:
University Hospital, Grenoble
Contacts:
Pierre PITTETppittet@chu-grenoble.fr
0476766872
Marine FAUREmfaure6@chu-grenoble.fr
0476766872
Government Study Link:
NCT06611891 - Click here to see study onClinicalTrials.gov
Isotope(s):
Target(s):
- SSTR+
Chelator: DOTA
